Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Lung Cancer ; 31(1): 67-72, 2001 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-11162868

RESUMO

A total of 29 previously untreated patients with histologically proven malignant pleural mesothelioma, with an ECOG score of < or = 2 and UICC stage I-II disease, were enrolled between May 1994 and October 1996. On days 1 and 2, 18 x 10(6) IU/day of rIL-2 was administered by continuous intravenous infusion, and 6 x 10(6) IU/day of rIL-2 by subcutaneous injection on days 5--20 inclusive of a 42-day cycle. Further treatment was administered if no radiological disease progression was demonstrated. A total of 29 patients were assessable for toxicity and 25 for response, and 49 cycles of IL-2 were administered with a median of one per patient (range, < 1-4). Toxicity included mild fever, nausea and vomiting, and skin rashes, < grade II. Three patients failed to complete one cycle of treatment because of toxicity and one died of disease before response evaluation. Two patients achieved a partial response (8%, 95% CI 1-26%) surviving 18.1 and 18.7 months from diagnosis. A total of 11 patients (44%, 95% CI 24-65%) with stable disease had a median survival of 13.6 months (range 6.5-33.8). The median survival was 8.6 months (range 3.7-34.5) for the 12 patients with progressive disease (48%, 95% CI 28-69%). This regimen of rIL-2 is well tolerated and shows limited activity in mesothelioma.


Assuntos
Interleucina-2/administração & dosagem , Mesotelioma/tratamento farmacológico , Neoplasias Pleurais/tratamento farmacológico , Adolescente , Adulto , Idoso , Progressão da Doença , Feminino , Humanos , Infusões Intravenosas , Injeções Subcutâneas , Interleucina-2/efeitos adversos , Interleucina-2/uso terapêutico , Masculino , Mesotelioma/patologia , Pessoa de Meia-Idade , Neoplasias Pleurais/patologia , Análise de Sobrevida , Resultado do Tratamento
2.
Behav Processes ; 19(1-3): 167-80, 1989 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-24895910

RESUMO

Hungry rats were trained to press one lever for a sucrose solution and another for food pellets on a concurrent schedule. The contingency between lever pressing and reinforcement was then reduced by delivering either free sucrose solution or free food pellets. The non-contingent schedule resulted in a greater reduction of pressing on the lever associated with the contiguous reinforcer that was the same as the free reinforcer. This finding suggests that the reduction in instrumental performance under a non-contingent schedule cannot be attributed solely to the development of competing responses.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...